Skip to content

A-TANGO highlights at EASL Congress 2023

The A-TANGO consortium performs Phase 2 clinical studies of an innovative therapeutic strategy that targets inflammation and improves hepatocyte proliferation. This novel combinatorial therapy is called G-TAK. In addition, A-TANGO strives to identify reliable biomarkers for better patient stratification and…

Read more

Forge the future of EASL’s governance!

Are you ready to boost your leadership skills in EASL’s governance?     EASL is now looking to fill the following positions:   Vice-Secretary  Treasurer  Public Health Councillor  One Scientific Committee Member  Two Young Investigators Task Force Members   Two Nurses & AHPs Task Force Members 

Read more
Back To Top